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Recently, potential forensic use of DNA epigenetic markers has been discussed for the identification of the 
107
Methylation assays show several advantages over conventional presumptive tests such as high sensitivity 108 and specificity to avoid cross-reactivity with other species or materials. Moreover, DNA as a target is 109 particularly appealing as DNA is more stable than RNA, allowing cell identification even in highly degraded of menstrual blood [17] [18] [19] [20] , one for the detection of saliva [20] , six for the detection of semen [17] [18] [19] [20] , and 129 two for the detection of venous blood [19, 20] (Table S1 ). Menstrual blood markers were intended to 130 identify vaginal fluid in the original studies [17] [18] [19] [20] and tested for their applicability to detect menstrual 131 blood in this study.
132
Sample collection and preparation
133
Body fluid samples were collected from 43 volunteers (16 females and 27 males) with informed consent 134 using procedures approved by the local ethical committee (Ethik-Kommission der Ärztekammer
135
Westfalen-Lippe und der Westfälischen Wilhelms-Universität Münster). Venous blood (n = 13) was 136 collected by venipuncture, and semen (n = 17) was collected in plastic cups. Both fluids were stored 137 frozen in 200 µl aliquots. Menstrual blood was obtained using sterile cotton swabs on the first three days 138 of the menses (n = 10 for each day), dried, and stored at room temperature. Saliva (n = 18) was collected 139 by cheek swabs using sterile cotton swabs and by discharging saliva into a tube. The cotton swabs were 140 dried, and stored at room temperature, and liquid saliva was stored frozen in 200 µl aliquots. For the initial 141 investigation of the markers in singleplex nine menstrual blood samples, ten saliva samples, six semen 142 samples, and ten venous blood samples were used. The sample set was increased from 9 to 30 143 menstrual blood, 10 to 18 saliva, 6 to 17 semen, and 10 to 13 venous blood samples for the development (Tables S2 and S3) . PCR primers were designed to amplify bisulfite-treated DNA. All primers
164
were synthesized by and purchased from Biomers (Germany) and diluted in water to reach a 165 concentration of 100 pmol/µl.
166
Primer reactivity and marker performance were tested in singleplex reactions. Subsequently, a multiplex 167 reaction was developed using the most tissue specific markers.
168
For the initial testing of all markers, primer concentrations ranged between 0. 
184
The multiplex assay was further used for a mixture analysis of fluid venous blood, fluid semen, fluid saliva,
185
and fluid menstrual blood from day one of the menses. This was done by combining bisulfite-converted
186
DNA from different body fluids 1:1 to ensure equal DNA concentrations, and analyzing the mixtures using 187 the developed multiplex assay. Additionally, the multiplex assay was tested for its applicability to crime 
Analysis criteria and statistical analysis
206
The relative methylation state (%) of each CpG site was determined by calculating the relative peak height fluids. In our study, the methylation state for PFN3 was found to be significantly lower in menstrual blood on these findings, the methylation state of PFN3 might be regarded as specific for menstrual blood; 235 however, although statistically significant differences were found between menstrual blood and semen, 236 31 % of the menstrual blood samples expressed a similar methylation state as 50 % of semen samples.
237
Marker PFN3 was therefore excluded from further analyses ( 
248
Consequently, this marker was not considered as a menstrual blood-specific marker for the final multiplex 249 (Fig.S1D) . were highly significant (p < 0.001), allowing to unambiguously distinguish saliva from semen, venous 254 blood, and menstrual blood (Fig.S2) . Thus, it was validated successfully as a saliva-specific marker and 255 was added to the final multiplex assay. 
257
The markers SE1 (Fig.3A) and SE2 (Fig.S3B) were successfully used for the detection of semen as only 258 semen samples expressed methylation (p < 0.001). These results support previous findings of on-/off-259 methylation [19, 20] and confirm SE1 and SE2 as semen-specific markers. In our study, SE2 showed lower 260 intersample variation than SE1 and was therefore included in the development of the final multiplex assay.
261
Relative methylation for the tDMR for marker USP49 (Fig.S1C) 
Multiplex SNaPshot assay 287
For the final multiplex assay only markers for which our findings confirmed results of previous studies and 288 allowed clear differentiation between body fluids were considered for the development of the final 289 multiplex assay. We found that only four markers allow complete differentiation between the four body 290 fluids: These markers showed to be the menstrual-blood specific marker VF2, the saliva-specific marker 291 SA1, the semen-specific marker SE2, and the venous blood-specific marker BL1. Figure 1A shows the developed multiplex SNaPshot assay including the four markers, exemplarily for one 293 sample of each body fluid sample: semen (Fig.1A1), saliva (Fig.1A2) , venous blood (Fig.A3) , and 294 menstrual blood of the three days of the menses (MB-1, MB-2, MB-3; Fig.1A4 -1A6 ). The markers were 
292
302
Marker VF2 expressed partial to strong methylation in menstrual blood from all three days of the menses 303 and nearly complete lack of methylation in all other body fluids (p < 0.001; Fig.2A) . Menstrual blood Marker SA1 exhibited significantly saliva-specific hypermethylation (p < 0.001) with an even higher 307 specificity compared to literature data [21] (Fig.2B) . High blue peaks were visible in the electropherograms 308 in saliva samples with complete lack of methylation or blue peaks in semen and menstrual blood samples. Although numerous venous blood samples (92 %) also expressed a very low level of methylation, they
311
were distinguishable by visual comparison of peak height: While saliva samples showed >90% 312 methylation in all samples analyzed, blood revealed <20% methylation in all samples.
313
Marker SE2 expressed significant semen-specific hypermethylation (p<0.001) with complete lack of 314 methylation in the remaining body fluids (Fig.2C) . Only in semen samples the blue peak, indicating 315 methylation, was visible while all other body fluids expressed a green peak, indicating no methylation.
316
Marker BL1 showed a significantly higher methylation state in venous blood compared to saliva, menstrual 317 blood (p < 0.001) and semen (p < 0.01; Fig.2D ). Even though BL1 expresses partial methylation in semen,
318
a combination of marker BL1 with marker SE2, being hypermethylated in semen and hypomethylated in 319 venous blood, aids in distinguishing venous blood samples from semen samples.
320
All markers showed to be highly stable with results from the initial multiplex analyses reliably reproduced 
339
The results show that marker SA1 expresses the same methylation profile in liquid saliva and buccal cells.
340
Semen-containing mixtures expressed a significantly higher methylation state in SE2 than non-semen-
341
containing mixtures (p < 0.001; Fig.S5C ). In BL1 (Fig.S5D) 
348
blood combined with semen ( Fig.1B1) , and menstrual blood combined with venous blood (Fig.1B2 ). 
350
Analysis of mock crime scene stains
356
The saliva-specific marker SA1 and the venous blood-specific marker BL1 both expressed partial 357 methylation with an overall stronger signal in BL1. The menstrual blood-specific marker VF2 as well as the 358 semen-specific marker SE2 were both hypomethylated. Based on this information it was accurately 359 determined that the major component of the mixture was venous blood and the minor component saliva. showed to be partially methylated while marker VF2 was hypomethylated. It was therefore determined that 367 the stain consisted of saliva, semen, and venous blood in equal concentrations. Stain C5 contained 10 µl
Conclusion 372
The main advantage of using DNA methylation assays over conventional presumptive tests or RNA based 373 methods is that it can be applied even after DNA testing. In all other test methods, a decision on whether
374
or not body fluid identification is necessary needs to be made by the analyst before a DNA typing result 
379
RNA/DNA co-extraction needs to be made before DNA typing results are available.
380
The results of this study suggest that a combination of only four highly informative markers will be enough 
401
BL1 should be used in combination with marker SE2 to exclude semen presence. blood from day 2 of the menses (=MB-2). The methylation state in PFN3 was significantly lower menstrual blood compared to saliva and venous blood (p < 0.001), and significantly higher than in semen (p < 0.01) (A). The tDMR for VF1 expressed statistically highly relevant differences in relative methylation between menstrual blood and semen as well as saliva (p ≤ 0.001). No statistically relevant differences between states of methylation between menstrual blood and venous blood were detected (B). In VF2 menstrual blood expressed significant hypermethylation compared to semen, saliva, and blood (p < 0.001) (C). Marker PRMT2 expressed highly statistically significantly greater methylation in menstrual blood than in semen (p < 0.001). Relative methylation in menstrual blood was statistically insignificantly different from relative methylation in saliva and venous blood. Circles represent outliers and asterisks represent extreme values. Relative methylation for USP49 (C) was significantly lower in semen compared to saliva, menstrual blood, and venous blood (p<0.001). In PRMT2 (D) relative methylation in semen was significantly lower than in menstrual blood, venous blood, and saliva (p < 0.001). In DACT1 (E) semen expressed significantly lower relative methylation than all other body fluids (p < 0.001).
Circles represent outliers and asterisks represent extreme values. higher methylation state than non-menstrual-blood-containing mixtures (p < 0.001). In SA1 (B) the saliva-containing mixtures expressed a significantly higher methylation state than non-salivacontaining mixtures (p < 0.001). In SE2 (C) semen-containing mixtures expressed a significantly higher methylation state non-semen-containing mixtures (p < 0.001). In BL1 (D) the mixture of venous blood and menstrual blood expressed a significantly greater methylation state than the mixtures of semen and saliva (p < 0.001), menstrual blood and saliva (p < 0.01), and menstrual blood and semen (p < 0.01). The mixture of venous blood and semen also expressed a significantly greater methylation state than the mixtures of semen and saliva, menstrual blood and saliva, and menstrual blood and semen (p < 0.001). The mixture of venous blood and saliva expressed a significantly higher methylation state than the mixture of semen and saliva (p < 0.001).
Circles represent outliers and asterisks represent extreme values. 
